A detailed history of Cowen And Company, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 898,630 shares of XGN stock, worth $1.64 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
898,630
Previous 898,630 -0.0%
Holding current value
$1.64 Million
Previous $1.79 Million 20.13%
% of portfolio
0.05%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$1.45 - $2.39 $1.3 Million - $2.15 Million
898,630 New
898,630 $1.79 Million
Q2 2023

Aug 07, 2023

SELL
$2.36 - $3.48 $238,775 - $352,092
-101,176 Reduced 10.72%
842,376 $2.44 Million
Q1 2023

May 09, 2023

SELL
$2.23 - $2.9 $50,108 - $65,163
-22,470 Reduced 2.33%
943,552 $2.29 Million
Q4 2022

Feb 09, 2023

SELL
$2.1 - $3.4 $763,058 - $1.24 Million
-363,361 Reduced 27.33%
966,022 $2.32 Million
Q3 2022

Nov 14, 2022

SELL
$3.43 - $8.68 $89,286 - $225,949
-26,031 Reduced 1.92%
1,329,383 $3.6 Million
Q2 2022

Aug 05, 2022

SELL
$4.18 - $7.74 $122,127 - $226,139
-29,217 Reduced 2.11%
1,355,414 $7.78 Million
Q3 2021

Nov 12, 2021

BUY
$10.25 - $15.21 $6.75 Million - $10 Million
658,553 Added 90.7%
1,384,631 $18.8 Million
Q2 2021

Aug 13, 2021

BUY
$12.4 - $17.92 $3.4 Million - $4.91 Million
274,257 Added 60.7%
726,078 $10.9 Million
Q1 2021

May 04, 2021

BUY
$13.9 - $22.0 $1.88 Million - $2.98 Million
135,271 Added 42.73%
451,821 $7.91 Million
Q4 2020

Feb 08, 2021

BUY
$11.19 - $16.05 $259,731 - $372,536
23,211 Added 7.91%
316,550 $4.18 Million
Q3 2020

Nov 03, 2020

SELL
$10.56 - $16.69 $1.47 Million - $2.32 Million
-139,063 Reduced 32.16%
293,339 $3.18 Million
Q2 2020

Aug 13, 2020

BUY
$11.0 - $16.7 $2.12 Million - $3.22 Million
192,731 Added 80.41%
432,402 $5.37 Million
Q1 2020

May 11, 2020

BUY
$12.7 - $25.95 $3.04 Million - $6.22 Million
239,671 New
239,671 $3.82 Million

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $29.6M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.